Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy

Diabetologia

Volumn 54, Issue 10, 2011, Pages 2525-2532

  Aspelund, T ^a,b   Porisdottir O ^b,c   Olafsdottir E ^a   Gudmundsdottir, A ^a,b   Einarsdottir A B ^a,b   Mehlsen, J ^d   Einarsson, S ^b   Palsson O ^b   Einarsson, G ^a,b   Bek, T ^b,d   Stefansson E ^a,b,e  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Risk Medical Solutions   (Iceland)

^c AARHUS UNIVERSITY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Risk assessment; Screening

Indexed keywords

ALGORITHM; ARTICLE; BLOOD PRESSURE; CLINICAL ASSESSMENT TOOL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PLANNING; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INFORMATION PROCESSING; INFORMATION TECHNOLOGY; INTERNET; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SYSTOLIC BLOOD PRESSURE;

ALGORITHMS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, THEORETICAL; RISK ASSESSMENT;

EID: 80054108790     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2257-7     Document Type: Article

References (34)

1. JC Javitt LP Aiello Y Chiang FL Ferris 3rd JK Canner S Greenfield 1994 Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform Diabetes Care 17 909 917 7956643 1:STN:280:DyaK2M%2FksVOhuw%3D%3D (Pubitemid 24235519)
2. E Stefansson T Bek M Porta N Larsen JK Kristinsson E Agardh 2000 Screening and prevention of diabetic blindness Acta Ophthalmol Scand 78 374 385 10990036 1:STN:280:DC%2BD3cvkt1Sqsw%3D%3D (Pubitemid 30609364)
3. TH Tung HC Shih SJ Chen P Chou CM Liu JH Liu 2008 Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan J Epidemiol 18 225 233 18776707
4. LB Backlund PV Algvere U Rosenqvist 1997 New blindness in diabetes reduced by more than one-third in Stockholm County Diabet Med 14 732 740 9300222 1:STN:280:DyaK2svksFegtQ%3D%3D (Pubitemid 27390853)
5. K Piwernetz PD Home O Snorgaard M Antsiferov K Staehr-Johansen M Krans 1993 Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee Diabet Med 10 371 377 8508624 1:STN:280:DyaK3s3osVygtA%3D%3D (Pubitemid 23134749)
6. PH Scanlon 2008 The English national screening programme for sight-threatening diabetic retinopathy J Med Screen 15 1 4 18416946 1:STN:280:DC%2BD1c3ls1OjsQ%3D%3D (Pubitemid 351629537)
7. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053 15111519 (Pubitemid 38579764)
8. EJ Dasbach DG Fryback PA Newcomb R Klein BE Klein 1991 Cost effectiveness strategies for detecting diabetic retinopathy Med Care 29 1 20 39 1898753 1:STN:280:DyaK3M%2FpsVeruw%3D%3D
9. Kalm H, Jonsson R (1993) Diabetic retinopathy screening. University of Gothenburg, Gothenburg
10. JK Kristinsson JR Gudmundsson E Stefansson F Jonasson I Gislason AV Thorsson 1995 Screening for diabetic retinopathy. Initiation and frequency Acta Ophthalmol Scand 73 525 528 9019377 1:STN:280:DyaK283ktVyksg%3D%3D (Pubitemid 26059864)
11. E Olafsdottir E Stefansson 2007 Biennial eye screening in patients with diabetes without retinopathy: 10-year experience Br J Ophthalmol 91 1599 1601 17627978 1:STN:280:DC%2BD2snot1CqsQ%3D%3D (Pubitemid 350207380)
12. UK Prospective Diabetes Study Group 1998 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 703 713
13. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853
14. R Klein BE Klein SE Moss KJ Cruickshanks 1998 The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes Ophthalmology 105 1801 1815 9787347 1:STN:280:DyaK1M%2FgtlKitw%3D%3D (Pubitemid 28509717)
15. EM Kohner IM Stratton SJ Aldington RR Holman DR Matthews 2001 Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52) Diabet Med 18 178 184 11318837 1:STN:280:DC%2BD3M3jtV2kuw%3D%3D (Pubitemid 32397854)
16. IM Stratton EM Kohner SJ Aldington, et al. 2001 UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis Diabetologia 44 156 163 11270671 1:STN:280:DC%2BD3M7ntlOhtw%3D%3D (Pubitemid 32156199)
17. UK Prospective 1991 Diabetes study (UKPDS). VIII. Study design, progress and performance Diabetologia 34 877 890
18. JK Kristinsson 1997 Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis Acta Ophthalmol Scand Suppl 223 1 76 9559048
19. JK Kristinsson H Hauksdottir E Stefansson F Jonasson I Gislason 1997 Active prevention in diabetic eye disease. A 4-year follow-up Acta Ophthalmol Scand 75 249 254 9253967 1:STN:280:DyaK2szpsF2rsg%3D%3D (Pubitemid 27315586)
20. JK Kristinsson E Stefansson F Jonasson I Gislason S Bjornsson 1994 Screening for eye disease in type 2 diabetes mellitus Acta Ophthalmol (Copenh) 72 341 346 1:STN:280:DyaK2M%2Fms1OltA%3D%3D (Pubitemid 24222014)
21. JK Kristinsson E Stefansson F Jonasson I Gislason S Bjornsson 1994 Systematic screening for diabetic eye disease in insulin dependent diabetes Acta Ophthalmol (Copenh) 72 72 78 1:STN:280:DyaK2c3oslyitw%3D%3D (Pubitemid 24099187)
22. RM Conroy K Pyörälä, et al. 2002 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987 1003
23. R Development Core Team (2009) A language and environment for statistical computing. Available from www.R-project.org. Accessed 1 July 2011
24. Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2009) Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol. doi: 10.1111/j.1755-3768.2009.01.742.x
25. Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2010) Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. doi: 10.1111/j.1755-3768.2010.01882.x
26. GM Zoega T Gunnarsdottir S Bjornsdottir AB Hreietharsson G Viggosson E Stefansson 2005 Screening compliance and visual outcome in diabetes Acta Ophthalmol Scand 83 687 690 16396645 (Pubitemid 41823816)
27. C Hansson-Lundblad K Holm CD Agardh E Agardh 2002 A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy Acta Ophthalmol Scand 80 310 315 12059872 (Pubitemid 34649934)
28. M Henricsson M Tyrberg A Heijl L Janzon 1996 Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme Acta Ophthalmol Scand 74 533 538 9017036 1:STN:280:DyaK2s7mvFCktA%3D%3D (Pubitemid 27042672)
29. P Jeppesen T Bek 2004 The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark Acta Ophthalmol Scand 82 526 530 15453847 (Pubitemid 39386962)
30. R Klein BE Kelin SE Moss 1993 Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 100 1140 1146 8341493 1:STN:280:DyaK3szktFyitw%3D%3D (Pubitemid 23226808)
31. P Zimmet KG Alberti J Shaw 2001 Global and societal implications of the diabetes epidemic Nature 414 782 787 11742409 1:CAS:528:DC%2BD38Xhtlymtg%3D%3D (Pubitemid 34000780)
32. H King RE Aubert WH Herman 1998 Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1414 1431 9727886 1:STN:280:DyaK1czpsVyluw%3D%3D (Pubitemid 28405191)
33. NR Cook 2008 Statistical evaluation of prognostic vs diagnostic models: beyond the ROC curve Clin Chem 54 17 23 18024533 1:CAS:528: DC%2BD1cXmtFemuw%3D%3D (Pubitemid 351182592)
34. HC van Houwelingen 2000 Validation, calibration, revision and combination of prognostic survival models Stat Med 19 3401 3415 11122504 (Pubitemid 32056693)